6-Chloro-2-(2-(1-methyl-3-(pyrrolidin-1-yl)-1H-1,2,4-triazol-5-yl)vinyl)-[1,2,4]triazolo[1,5-a]pyridine → 6-Chloro-2-(2-(1-methyl-3-(pyrrolidin-1-yl)-1H-1,2,4-triazol-5-yl)ethyl)-[1,2,4]triazolo[1,5-a]pyridine
反応式
[Cl:1][C:2]1[CH:3]=[CH:4][C:5]2[N:6]([N:8]=[C:9]([CH:11]=[CH:12][C:13]3[N:17]([CH3:18])[N:16]=[C:15]([N:19]4[CH2:23][CH2:22][CH2:21][CH2:20]4)[N:14]=3)[N:10]=2)[CH:7]=1>CCOC(C)=O.[Pd]>[Cl:1][C:2]1[CH:3]=[CH:4][C:5]2[N:6]([N:8]=[C:9]([CH2:11][CH2:12][C:13]3[N:17]([CH3:18])[N:16]=[C:15]([N:19]4[CH2:23][CH2:22][CH2:21][CH2:20]4)[N:14]=3)[N:10]=2)[CH:7]=1参加物
4
反応物 1
生成物 1
試薬・触媒・溶媒 2
実験手順
A suspension of 6-chloro-2-(2-(1-methyl-3-(pyrrolidin-1-yl)-1H-1,2,4-triazol-5-yl)vinyl)-[1,2,4]triazolo[1,5-a]pyridine (50 mg, 152 μmol, Eq: 1.00) and 5% Pd on Ba2SO4 (150 mg) in EtOAc (5 ml) was stirred under hydrogen (1 atm) for 2 h. The mixture was filtered over Celite and the residue purified by prep. HPLC to give the desired product (7.7 mg, 15%) as a white solid. MS: m/z=331.9 (M+H+)
後処理
- filtrationThe mixture was filtered over Celite
- customthe residue purified by prep
出典と根拠
- ORDレコード
- ord-a06b3ca0ee48487cad62832b3760660c
- 出典データセット
- uspto-grants-2016_07
- 特許番号
- US09394311B2
反応ノート
読み込み中…